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OBJECTIVES The purpose of this study was to investigate the classification of cardiovascular risk in young
individuals and women according to the National Cholesterol Education Program (NCEP)
guidelines across a continuum of coronary calcium scores (CCS).
BACKGROUND Current NCEP guidelines might underestimate cardiovascular risk in young individuals and
women.
METHODS The study population consisted of 1,611 asymptomatic individuals (67% men, mean age:
53  10 years) who presented to a single electron beam tomography facility for coronary
artery calcium screening. Participants were categorized into low-risk (n  738, 46%),
intermediate-risk (n  583, 36%), moderately high-risk (n  263, 16%), and high-risk (n 
27, 2%) according to the NCEP Panel III guidelines.
RESULTS Absence of calcium, CCS of 0 to 99 (mild), 100 to 399 (moderate), and 400 (severe), was
observed in 572 (35%), 707 (44%), 192 (12%), and 140 (9%) of the patients, respectively. A
high CCS percentile (75th percentile) was present in 426 (26%) individuals. Overall, 59%
and 78% of participants with CCS 400 and CCS 75th percentile were not identified as
high risk and candidates for pharmacotherapy on the basis of NCEP categories. Furthermore,
women as well as young individuals were less likely to be considered candidates for
pharmacotherapy compared with men and older individuals in each CCS category.
CONCLUSIONS The NCEP guidelines seem to underestimate cardiovascular risk in young asymptomatic
individuals and women. For these individuals, assessment of plaque burden might provide
incremental value to global risk assessment. (J Am Coll Cardiol 2005;46:1931–6) © 2005
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.052by the American College of Cardiology Foundation
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coronary heart disease (CHD) affects over one million
mericans annually and is the leading cause of death in the
.S., having caused nearly one-half of a million deaths
mong the adult population in 2001 (1). As many as
ne-half of the first coronary events (including sudden
ardiac death) occur in asymptomatic people (2), which
nderscores the importance of detecting individuals at risk
efore an initial event to implement primary prevention
trategies (3).
The primary recommendation of several advisory bodies
s that all adults undergo an office-based assessment as the
nitial step to identify those at higher risk for CHD. One
pproach adopted by the National Cholesterol Education
rogram Panel III (NCEP-III) is to apply a modification of
he risk prediction algorithm derived from the Framingham
eart Study to estimate a person’s 10-year risk for devel-
ping CHD (3,4). The NCEP-III guidelines suggest using
he Framingham risk categories to target low-density li-
oprotein (LDL) as the primary goal of preventive treat-
ent (4,5). A potential limitation of the NCEP-III guide-
From the *Department of Medicine, University of Pittsburgh, Pittsburgh, Penn-
ylvania; †The Ciccarone Preventive Cardiology Center, Johns Hopkins University
chool of Medicine, Baltimore, Maryland; and the ‡Section of Cardiology, Tulane
niversity, New Orleans, Louisiana.g
Manuscript received May 10, 2005; revised manuscript received July 1, 2005,
ccepted July 19, 2005.ines is the underestimation of risk in young individuals and
omen, as highlighted in previous reports (6,7).
Identification of subclinical atherosclerosis and coronary
laque burden might help to improve identification of
igh-risk individuals. Evidence exists that coronary calcium
cores (CCS) quantified by electron beam tomography
EBT) are a reasonable surrogate for coronary atheroscle-
osis burden in adults (8–10). Furthermore, in recent years,
number of studies have demonstrated the independent
rognostic value of increasing CCS in predicting future
HD events in asymptomatic individuals (11–17).
Several reports have shown that CCS 400 and CCS
75th percentile for age-gender are associated with a
ignificant CHD risk (11,15,16). Experts from the NCEP-
II panel have recommended quantification of CCS as an
ption for advanced risk assessment in the intermediate-risk
ategories and indicated that a high CCS (e.g., 75th
ercentile for age and gender) provides a rationale for
ntensified medical therapy.
Our study was designed to investigate the eligibility for
harmacotherapy according to NCEP-III guidelines among
symptomatic individuals across a spectrum of CCS. Sec-
ndarily, we evaluated whether a difference in risk stratifi-
ation by NCEP-III guidelines existed across age and
ender in individuals with similar atherosclerotic burden.
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tudy population. This is a cross-sectional study on a
onsecutive sample of 2,046 physician-referred patients who
resented to a single EBT scanning facility. We excluded
04 subjects who reported a history of prior myocardial
nfarction, or coronary and/or peripheral arterial revascular-
zation, current symptoms suggestive of angina, and indi-
iduals with diabetes, because they are considered CHD-
quivalent irrespective of baseline risk. Additionally, 31
ndividuals reporting use of cholesterol-lowering medica-
ions were also excluded from the analyses. This was done
ecause we used fasting lipid levels to calculate a Framing-
am risk score and the use of lipid-lowering agents could
ave interfered with our risk assessment. The study was
pproved by the local institutional review board and received
waiver of patient consent.
isk-factor assessment and calculation of 10-year CHD
isk. All individuals provided details of their demographics,
edical history, medication usage, and current symptoms
by means of questionnaire offered at the time of first
canning). Hypertension was defined by current or recom-
ended use of antihypertensive medications for blood
ressure control. Smoking was defined as current tobacco
sage. Family history of CHD was defined as CHD in
rst-degree male relatives 55 years of age or female
elatives 65 years old. Body mass index was calculated as
eight (kg)/height (m)2. Young age was defined for men as
ge 55 years and, for women, 65 years.
Fasting total cholesterol and triglycerides were deter-
ined with enzymatic methods on samples drawn on the
ame day as the EBT. High-density lipoprotein (HDL)
holesterol was measured after precipitation of apolipopro-
ein B containing particles with phosphotungstate. Low-
ensity lipoprotein cholesterol was calculated with the
riedewald equation.
We categorized participants into low-risk (0 to 1 risk
actors), intermediate-risk (2 risk factors but10% risk of
HD at 10 years), moderately high-risk (2 risk factors
nd 10% to 20% risk of CHD in10 years), or high-risk (2
isk factors and 20% risk of CHD in 10 years) groups,
ccording to the most recent NCEP guidelines (5). Risk
actors considered were cigarette smoking, hypertension
blood pressure 140/90 mm Hg or receiving antihyper-
ensive medication), low HDL cholesterol (40 mg/dl),
amily history of premature CHD (CHD in male first-
Abbreviations and Acronyms
CCS  coronary calcium score
CHD  coronary heart disease
EBT  electron beam tomography
HDL  high-density lipoprotein
LDL  low-density lipoprotein
NCEP  National Cholesterol Education Programegree relative 55 years of age; CHD in female first-
H
cegree relative 65 years of age), and age (men 45 years;
omen 55 years). The LDL cholesterol cutoffs recom-
ended by the NCEP III guidelines for initiation of
ipid-lowering therapy in each risk category are as follows:
ow-risk (190 mg/dl), intermediate-risk (160 mg/dl),
oderately high-risk (130 mg/dl), and high-risk (100
g/dl) (4).
BT. Each patient underwent EBT scanning with a GE
matron C-150 scanner (GE/Imatron, South San Fran-
isco, California). Coronary arteries were imaged with rapid
cquisition of 30 to 40 contiguous slices with a thickness of
mm (26-cm2 field of view) during end-diastole. Image
cquisition was electrocardiographically triggered and oc-
urred during a single 30- to 35-s breath hold. Coronary
alcium score was quantified with the previously described
gatston scoring method (18). Calcium was considered
resent in a coronary artery when a density of 130
ounsfield units was detected in 3 contiguous pixels
1.03 mm3) overlying that coronary artery. The CCS was
omputed from the product of the attenuation factor and
he area of a calcification. A total CCS was computed as the
um of all scores from all individual lesions in each coronary
rtery.
To facilitate data interpretation, the CCS was classified
nto the following categories: 0, 1.0 to 99, 100 to 399, and
400 (no identifiable plaque, mild, moderate, and severe
therosclerotic plaque burden, respectively). These catego-
ies of CCS have been used to differentiate between very
ow, moderate, moderately high, and high cardiovascular
isk (19). A CCS 75th percentile for age- and gender-
atched individuals was also considered as an indicator of
igh-risk, as suggested in prior reports (11,14,15). The
utoffs for CCS 75th percentile were derived from a
ecent study demonstrating the normal distribution of CCS
n 12,936 asymptomatic individuals (20).
tatistical analysis. Continuous variables are expressed as
ean  SD. Descriptive statistics were used to summarize
atient characteristics. Tests of significance between groups
ere determined with Student t test for continuous variables
nd chi-square analysis for categorical variables. The asso-
iation between increasing 10-year CHD risk categories and
he extent of subclinical atherosclerosis as measured by CCS
as examined with logistic regression. For each model, the
able 1. Clinical Characteristics of Study Population (n  1,611)
Variables
ge (yrs) 53  10
en 1,080 (67%)
ypertension 193 (12%)
urrent smoker 242 (15%)
ody mass index (kg/m2) 28  5
C (mg/dl) 215  41
DL-C (mg/dl) 136  35
DL-C (mg/dl) 51  26
G (mg/dl) 142  88DL-C  high-density lipoprotein cholesterol; LDL-C  low-density lipoprotein
holesterol; TC  total cholesterol; TG  triglycerides.
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November 15, 2005:1931–6 Risk Assessment in the Young and Womeneference group comprised negative scores (CCS  0). All
tatistical analyses were performed with Stata version 8.0
Stata Corp., Austin, Texas). The level of significance was
et at p  0.05 (two-tailed).
ESULTS
he final study population consisted of 1,611 asymptomatic
en and women. Demographic and clinical characteristics
f the study population are shown in Table 1. The mean age
f the study population (67% men) was 53  10 years, and
he majority of individuals were relatively young (men 55
ears and women 65 years). Over one-half (54%) of the
articipants had 2 CHD risk factors.
oronary artery calcium scores. Table 2 shows the distri-
ution of absolute CCS among men and women. The
edian (interquartile range) CCS was 6 (0 to 67). Overall
alcium scores of 0, 1 to 99, 100 to 399, and 400 were
bserved in 35%, 44%, 12%, and 9% of the study subjects,
espectively. Advanced CCS (75th percentile) was present
n 426 (26%) individuals. As compared with women, men
ad a higher prevalence of any CCS (72% vs. 50%, p 
.00001) as well as moderate-to-severe CCS (25% vs. 13%,
 0.0001), respectively. This trend was observed in both
oung and older participants.
en-year CHD risk. The mean overall 10-year CHD risk
as 5.4  5.2%, with a higher risk observed in men than in
able 2. Distribution of Coronary Calcium Scores (CCS)
n the Study Population
Total <55 yrs >55 yrs
Men (n  1,080) (n  697) (n  383)
CS  0 306 (28%) 259 (37%) 47 (12%)
CS 1–99 512 (47%) 364 (52%) 148 (39%)
CS 100–399 147 (14%) 56 (8%) 91 (24%)
CS 400 115 (11%) 18 (3%) 97 (25%)
Women
Total <65 yrs >65 yrs
(n  531) (n  426) (n  105)
CS  0 266 (50%) 240 (57%) 26 (25%)
CS 1–99 195 (37%) 154 (36%) 41 (39%)
CS 100–399 45 (8%) 27 (6%) 18 (17%)
CS 400 25 (5%) 5 (1%) 20 (19%)
Table 3. Risk Stratification According to Natio
Guidelines in the Study Population
Men
Low risk (0–1 risk factors)
Intermediate risk (2 risk factors  10-yr risk 10%
Moderately high risk (2 risk factors  10-yr risk 1
High risk (2 risk factors  10-yr risk 20%)
Women
Low risk (0–1 risk factors)
Intermediate risk (2 risk factors  10-yr risk 10%
Moderately high risk (2 risk factors  10-yr risk 1
High risk (2 risk factors  10-yr risk 20%)omen (6.9  5.6% vs. 2.4  2.2%, p  0.0001). The
ajority of individuals were categorized as low- and
ntermediate-risk, with very few men considered at high risk
Table 3). No women were classified as being at high risk.
elationship of CCS and 10-year CHD risk. Although
ndividuals with higher calculated 10-year CHD risk
howed greater odds of higher CCS levels (Table 4), very
ew individuals with even moderately and severely elevated
CS were classified as high-risk by the NCEP guidelines
Fig. 1). Interestingly, one-quarter of each of the partici-
ants with CCS 100 to 399 and CCS 400 were classified
s low risk according to the NCEP guidelines.
ligibility for pharmacotherapy across CCS levels. The
revalence of individuals not qualifying for pharmacother-
py decreased as the CCS increased (p  0.001). Nonethe-
ess, 59% of the individuals with CCS 400 did not meet
riteria for drug therapy (Fig. 2). Similarly, 309 (73%) of
26 participants with CCS 75th percentile would not
ave qualified for drug therapy. These discrepancies were
articularly marked for women and young individuals com-
ared with men and older individuals in each CCS category
Figs. 3 and 4).
ISCUSSION
raditional risk factors and the calculated Framingham risk
core are currently used to define the odds of incident CHD
n asymptomatic individuals and to identify high-risk indi-
iduals who are candidates for preventive pharmacotherapy
4,5). The decision-making process to determine the inten-
Cholesterol Education Program-III
Total <55 yrs >55 yrs
(n  1,080) (n  697) (n  383)
422 (39%) 326 (47%) 96 (25%)
376 (35%) 277 (40%) 99 (26%)
%) 255 (24%) 86 (12%) 169 (44%)
27 (2%) 8 (1%) 19 (5%)
Total <65 yrs >65 yrs
(n  531) (n  426) (n  105)
316 (60%) 284 (66%) 32 (30%)
207 (39%) 141 (33%) 66 (63%)
%) 8 (1%) 1 (1%) 7 (7%)
able 4. Odds Ratio for Increasing Coronary Calcium Scores
CCS) With Higher 10-Year Coronary Heart Disease
alculated Risk
Low Risk
Intermediate
Risk
Moderately High to
High Risk
CS 1–99 1 (reference) 2.5 (1.9–3.2) 5.0 (3.3–7.5)
CS 100–399 1 (reference) 3.6 (2.4–5.4) 15.4 (9.3–25.5)
CS 400 1 (reference) 2.8 (1.7–4.4) 15.8 (9.2–26.9)
or each model, the reference group comprised negative scores (CCS  0).
ndividuals classified as high risk (2 risk factors and 10-year risk 20%) were
ombined with those categorized as moderately high risk (2 risk factors and 10-year
isk 10–20%).nal
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Risk Assessment in the Young and Women November 15, 2005:1931–6ity of primary prevention is based on guidelines that
xtrapolate conclusions from population studies; however,
uch assessments might fall short if relied upon too strictly
or individual patient management (21–24). The use of
CEP-III guidelines alone in our asymptomatic study
opulation would have resulted in withholding of drug
reatment in 65% and 59% of the individuals with CCS
100 and CCS400, respectively, both important markers
f risk for future CHD (19).
The relative weakness of the NCEP-III guidelines to
etect high-risk individuals was recently highlighted by the
ork of Akosah et al. (6), who showed that 75% of 222
symptomatic young adults presenting with their first and
nheralded myocardial infarction would not have been
onsidered candidates for statin therapy in the days preced-
ng the event (6). Furthermore, Hecht et al. (7) demon-
trated that only 59% of 304 asymptomatic women submit-
ed to EBT screening were correctly identified by NCEP
uidelines as either high or low risk.
Whereas the decision to initiate drug therapy currently
ests on the basis of risk factors alone, an alternative—and
otentially more accurate—approach could be to target
igure 1. Relationship of coronary calcium scores (CCS) and National
holesterol Education Program (NCEP)–defined risk categories. Risk
evels: gray bars  low risk; white bars  intermediate risk; dotted bars
moderately high risk; black bars  high risk.b
w
igure 2. Proportion of individuals not qualifying for pharmacotherapy
cross increasing coronary calcium scores (CCS).atients with extensive subclinical atherosclerosis that pro-
ides the framework for clinical manifestations (24). The
nal evidence that such an approach would be preferable is
till missing. Nonetheless, a few moderate- to large-size
tudies (16,17,25) have already shown the incremental
rognostic value provided by anatomical information (i.e.,
oronary calcium) over traditional risk factors. Receiving
perator characteristic curves were used to assess the relative
ontribution of traditional risk factors and CCS for the
rediction of myocardial infarction, cardiac death (17,25),
nd all-cause mortality (16) in a total of approximately
2,000 asymptomatic individuals. All studies consistently
emonstrated the incremental prognostic value of CCS
eyond traditional risk factors to predict outcome, estab-
ishing a potentially very important role for CCS. There is,
owever, an important limitation inherent in the analyses
entioned above that deserves mention. In each of the
tudies, the greater predictive power of CCS was demon-
trable in patients at intermediate pre-test probability of
isease on the basis of conventional risk factors. Because the
ikelihood of developing CHD increases with age and
hronological age is the most weighted of the risk factors
igure 3. Proportion of men and women not qualifying for pharmacother-
py across increasing coronary calcium scores (CCS). White bars  men;
lack bars  women.
igure 4. Proportion of young and old individuals not qualifying for
harmacotherapy across increasing coronary calcium scores (CCS). White
ars  men 55 years, women 65 years; black bars  men 55 years,
omen 65 years.
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November 15, 2005:1931–6 Risk Assessment in the Young and Womenonsidered in the Framingham equations, young individuals
re less likely to be classified at intermediate and high risk
ompared with older subjects. In recognition of this impor-
ant limitation of the scoring algorithms, Grundy (26)
uggested that “calcium scores [be] used. . .to replace age as
risk factor in Framingham risk equation,” because they are
reliable measure of coronary plaque burden. Although
CS screening could not be proposed for all adults, for
bvious cost and safety concerns, testing might be of great
dditional help in refining risk assessment in young patients
as defined in this article) and women who are at least at low
o intermediate risk (approximately 6% CHD risk at 10
ears). This would limit the number of “missed opportuni-
ies” to aggressively treat patients at greater risk to develop
vents. Evidence to support the latter notion already exists.
n a prior study (11), 70% of the myocardial infarctions and
eaths occurred in patients with a baseline CCS 75th
ercentile, whereas the event rate in those with absent
oronary calcium has been consistently reported to average
.1% to 0.2% per year (11,16,17,25). Furthermore, in a
ecent analysis comparing cardiovascular outcome in gen-
ers after EBT screening, women seemed to benefit incre-
entally more than men from identification and quantifi-
ation of plaque burden (27).
The results of our study extend prior reports on the
imitations of the Framingham algorithms as a tool to
stimate risk in the individual patient. After assessing
ligibility for pharmacotherapy across a spectrum of CCS in
large population (n  1,611) of asymptomatic men and
omen, we concluded that, despite the presence of a
ubstantial atherosclerotic burden, a large number of indi-
iduals (especially young subjects and women) would not
ualify for pharmacotherapy. Our contention that risk
ssessment might benefit from the implementation of im-
ging modalities for atherosclerosis, although supported by
everal pieces of evidence already present in the literature,
waits final demonstration from the completion of longitu-
inal studies such as the Multi-Ethnic Study of Atheroscle-
osis (28) and the Heinz-Recall Study (29), even though
uch studies might not be completed until the end of the
urrent decade.
Our study presents several limitations. The authors ac-
nowledge that the purpose of risk assessment in NCEP-III
s to predict CHD and not coronary atherosclerosis; how-
ver, recent studies have provided strong support for the
elationship between increasing CCS (i.e., atherosclerosis)
nd risk of future CHD events. The study population likely
howed a selection bias, because subjects might have been
trongly motivated to assess their CHD risk and could
fford the expense associated with undergoing EBT screen-
ng. Also, the study population was mainly composed of
aucasians, and the findings might not apply to other racial
roups.
In summary, our study highlights the limitation of
CEP-III guidelines in identifying asymptomatic individ-als, especially women and the young, who harbor signifi-ant coronary atherosclerosis and are likely at high risk for
HD. For these individuals, assessment of plaque burden
ould help refine risk assessment and, as a result, have a
ignificant impact in the prevention of the leading cause of
eath in the U.S. population.
eprint requests and correspondence: Dr. Paolo Raggi, 1430
ulane Avenue, SL-48, New Orleans, Louisiana 70112. E-mail:
raggi@excite.com.
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